RX-3117: Phase Ib data

Data from 41 patients with solid tumors in the Phase Ib portion of an open-label, dose-escalation, U.S. Phase Ib/IIa trial

Read the full 205 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE